Headache associated with estrogen withdrawal (Q103862): Difference between revisions

@@ description / pt-br / description / pt-br @@
+Cefaleia ou migrânea se desenvolvendo dentro de cinco dias após o consumo diário de estrogênio exógeno por três semanas ou mais, que foi interrompido (geralmente durante o intervalo sem pílula dos anticoncepcionais orais combinados ou após um curso de reposição ou suplementação de estrogênio). Ele se resolve espontaneamente em três dias, na ausência de consumo posterior.
@@ description / en / description / en @@
+Headache or migraine developing within five days after daily consumption of exogenous estrogen for three weeks or longer, which has been interrupted (usually during the pill-free interval of combined oral contraceptives or following a course of replacement or supplementary estrogen). It resolves spontaneously within three days in the absence of further consumption.
@@ Property / Canonical URI @@
+https://id.who.int/icd/entity/59764378
@@ Property / Canonical URI: https://id.who.int/icd/entity/59764378 / rank @@
+Normal rank
@@ Property / CURIE @@
+CID11:ID_59764378
@@ Property / CURIE: CID11:ID_59764378 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-ID_59764378
@@ Property / Canary Token: dki-india-ID_59764378 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-16T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-16T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 16 August 2026 / rank @@
+Normal rank

Latest revision as of 09:38, 17 August 2026

Headache or migraine developing within five days after daily consumption of exogenous estrogen for three weeks or longer, which has been interrupted (usually during the pill-free interval of combined oral contraceptives or following a course of replacement or supplementary estrogen). It resolves spontaneously within three days in the absence of further consumption.

Language	Label	Description	Also known as
default for all languages	ID_59764378
English	Headache associated with estrogen withdrawal	Headache or migraine developing within five days after daily consumption of exogenous estrogen for three weeks or longer, which has been interrupted (usually during the pill-free interval of combined oral contraceptives or following a course of replacement or supplementary estrogen). It resolves spontaneously within three days in the absence of further consumption.